Sultatos L G
Department of Pharmacology, University of Medicine and Dentistry of New Jersey, Newark 07103-2757.
Drug Metab Dispos. 1987 Sep-Oct;15(5):613-7.
Mouse livers perfused in situ with the pesticide methyl parathion (O,O-dimethyl O-P-nitrophenyl phosphorothioate) resulted in the appearance of the toxic metabolite, methyl paraoxon (O,O-dimethyl-O-P-nitrophenyl phosphate), in the effluent perfusate. Mouse whole blood rapidly detoxified methyl paraoxon in vitro, but not at a rate sufficient to prevent transport of at least some of this toxic metabolite from liver to other tissues in vivo. The hepatic disposition and biotransformation of methyl parathion in perfused livers were altered markedly by changes in protein binding of methyl parathion to perfusate, but only slightly by changes in perfusate flow rates that maintained viable livers. Pretreatment of mice with phenobarbital daily for 4 days (80 mg/kg, ip) induced hepatic microsomal activation of methyl parathion to methyl paraoxon in vitro and increased the clearance of methyl parathion by perfused mouse livers. However, in contrast to perfusion of methyl parathion into livers from saline-pretreated mice, perfusion of methyl parathion into livers from phenobarbital-pretreated mice did not lead to the appearance of methyl paraoxon in effluent perfusate. Nevertheless, methyl paraoxon was produced intrahepatically during these perfusions since hepatic cholinesterase activities were depressed compared to livers from phenobarbital-pretreated mice perfused without methyl parathion. Furthermore, phenobarbital pretreatment antagonized the acute toxicity of methyl parathion in vivo in the mouse. These data demonstrate that the net result of the biotransformation of methyl parathion by livers in untreated mice is metabolic activation, whereas the net result by livers of phenobarbital-pretreated mice is detoxification.(ABSTRACT TRUNCATED AT 250 WORDS)
用杀虫剂甲基对硫磷(O,O - 二甲基 - O - 对硝基苯基硫代磷酸酯)对小鼠肝脏进行原位灌注后,流出的灌注液中出现了有毒代谢产物对氧磷甲基(O,O - 二甲基 - O - 对硝基苯基磷酸酯)。小鼠全血在体外能迅速使对氧磷甲基解毒,但解毒速度不足以阻止这种有毒代谢产物在体内从肝脏转运至其他组织。灌注肝脏中甲基对硫磷的肝脏处置和生物转化因甲基对硫磷与灌注液的蛋白结合变化而显著改变,但因维持肝脏存活的灌注液流速变化而改变较小。每天给小鼠腹腔注射苯巴比妥(80毫克/千克),连续4天,可诱导肝脏微粒体在体外将甲基对硫磷激活为对氧磷甲基,并增加灌注小鼠肝脏对甲基对硫磷的清除率。然而,与向生理盐水预处理小鼠的肝脏灌注甲基对硫磷不同,向苯巴比妥预处理小鼠的肝脏灌注甲基对硫磷不会导致流出的灌注液中出现对氧磷甲基。尽管如此,在这些灌注过程中肝脏内仍产生了对氧磷甲基,因为与未灌注甲基对硫磷的苯巴比妥预处理小鼠的肝脏相比,灌注甲基对硫磷的肝脏胆碱酯酶活性降低。此外,苯巴比妥预处理可拮抗甲基对硫磷在小鼠体内的急性毒性。这些数据表明,未处理小鼠肝脏对甲基对硫磷进行生物转化的最终结果是代谢激活,而苯巴比妥预处理小鼠肝脏的最终结果是解毒。(摘要截短至250字)